MedTrace Logo

Pathological Fracture in Potentially Unstable Spinal Metastases of Breast Cancer

NCT03365973 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-10-08

No results posted yet for this study

Summary

The purpose of this study is to identify potential risk factors for and determine the rate of pathological fracture for patients which having spine metastases from breast cancer and be defined as potentially unstable (SINS 7-12) according to the Spinal Instability Neoplastic Score (SINS). The investigators' analysis will provide robust data about the development of spinal instability and help identify the optimal timing of local surgery treatment.

Conditions

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Yuhui Shen, Ph.D., M.D. · Ruijin Hospital

  • Weibin Zhang, Ph.D., M.D. · Ruijin Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-15
Primary Completion
2022-12-15
Completion
2022-12-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365973 on ClinicalTrials.gov